Contract 75A50322F80030
Chartwell Rx Llc · Department Of Health And Human Services · September 26, 2022
Chartwell Rx Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2022 for $99.05 million of work in pharmaceutical preparation manufacturing. Performance is in Congers, NY. This is a task or delivery order issued under parent IDIQ 36F79720D0198. It was awarded under a small business set-aside. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 24, 2026.
Contract details
- PIID
- 75A50322F80030
- Parent IDIQ
- 36F79720D0198
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Congers, NY
- First action
- September 26, 2022
- Latest action
- March 24, 2026
Description
THE PURPOSE OF THIS MODIFICATION IS TO DESCOPE AMOXICILLIN TRIHYDRATE 500 MG CLINS.
Modification timeline
-
March 24, 2026Mod P00007 · Change Order$99.05M
-
February 20, 2026Mod P00006 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS$139.68M
-
January 30, 2026Mod P00005 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS$139.68M
-
December 29, 2025Mod P00004 · Supplemental Agreement For Work Within ScopeTHE PURPOSE OF THIS MODIFICATION IS FOR AMOXICILLIN TRIHYDRATE 500 MG CLINS$139.68M
-
June 27, 2025Mod P00003 · Change OrderTHE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE.$139.68M
-
September 24, 2024Mod P00002 · Other Administrative ActionTHE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE.$139.68M
-
September 26, 2022Base awardDOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES$139.68M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50322F80030?
Contract 75A50322F80030 is a federal contract awarded to Chartwell Rx Llc by Department Of Health And Human Services on September 26, 2022 for $99.05 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract 75A50322F80030?
Chartwell Rx Llc won contract 75A50322F80030 from Department Of Health And Human Services.
How much is contract 75A50322F80030 worth?
Contract 75A50322F80030 has obligated $99.05 million to date.